Contrast-induced Acute Kidney Injury: Specialty-specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2009 Feb 3

PMID 19181651

Citations 43

Authors

Stanley Goldfarb

Peter A McCullough

John McDermott

Spencer B Gay

Affiliations

Soon will be listed here.

Abstract

Contrast-induced acute kidney injury (AKI) (also known as contrast-induced nephropathy) is an abrupt deterioration in renal function that can be associated with use of iodinated contrast medium. Although the increase in serum creatinine concentration is transient in most cases, contrast-induced AKI may lead to increased morbidity and mortality rates in selected at-risk populations. This review summarizes the findings of a multidisciplinary panel composed of computed tomography radiologists, interventional radiologists, cardiologists, and nephrologists convened to address the specialty-specific issues associated with minimizing the incidence of contrast-induced AKI. As part of this initiative, the panel developed specialty-specific protocols for preventing contrast-induced AKI, taking into account, for example, the variations in patient risk profile, inpatient or outpatient status, and staffing resources that characterize various clinical settings. The 3 protocols, each reflecting a consensus of expert opinion, address the prevention of contrast-induced AKI in interventional radiology, diagnostic computed tomography radiology, and interventional cardiology settings. The protocols are presented in the context of a review of recent guidelines and published reports of trials that discuss contrast-induced AKI and its prevention. The panel reviewed materials retrieved by a PubMed search covering the period January 1990 through January 2008 and used combinations of key words associated with the prevention and treatment of contrast-induced AKI. In addition, the panel reviewed the reference lists of selected articles and the tables of contents posted on the Web sites of selected journals for relevant publications not retrieved in the PubMed searches.

Citing Articles

Personalized contrast agent dosing to prevent contrast induced nephropathy in high risk populations in Guangdong, China.

Liao M, Yang Y, Chen Y, Zhou Y, Zhou W, Zhou G Sci Rep. 2025; 15(1):6938.

PMID: 40011557 PMC: 11865306. DOI: 10.1038/s41598-025-91986-x.

Impact of white blood cell count on the development of contrast-induced acute kidney injury in patients receiving percutaneous coronary intervention.

Fu C, Ouyang C, Yang G, Li J, Chen G, Cao Y PeerJ. 2024; 12:e17493.

PMID: 39670095 PMC: 11636986. DOI: 10.7717/peerj.17493.

Differential Incidence of Contrast-Associated Acute Kidney Injury: Comparing Intravenous and Intraarterial Contrast Administration.

Guhan M, Shalaby M, Sharifeh T, Abdulla A, Jneid H, Allencherril J Curr Cardiol Rep. 2024; 26(8):833-841.

PMID: 39012549 DOI: 10.1007/s11886-024-02083-w.

An adult and pediatric size-based contrast administration reduction phantom study for single and dual-energy CT through preservation of contrast-to-noise ratio.

Wang J, Duan X, Mahmood U, McKenney S, Brady S J Appl Clin Med Phys. 2024; 25(5):e14340.

PMID: 38605540 PMC: 11087157. DOI: 10.1002/acm2.14340.

Is It Safe to Do Percutaneous Coronary Intervention in Moderate to Severe Chronic Kidney Disease Patients? A Prospective Cohort Study.

Santosa Y, Harca A, Yuwono A, Hermanto A, Oliver M, Sukmadja E Cureus. 2022; 14(10):e30312.

PMID: 36407165 PMC: 9659496. DOI: 10.7759/cureus.30312.

References

Firestone D, Wos A, Killeen J, Chan T, Guluma K, Davis D . Can urine dipstick be used as a surrogate for serum creatinine in emergency department patients who undergo contrast studies?. J Emerg Med. 2007; 33(2):119-22. DOI: 10.1016/j.jemermed.2007.02.021. View

Jo S, Youn T, Koo B, Park J, Kang H, Cho Y . Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol. 2006; 48(5):924-30. DOI: 10.1016/j.jacc.2006.06.047. View

King 3rd S, Smith Jr S, Hirshfeld Jr J, Jacobs A, Morrison D, Williams D . 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New.... Circulation. 2007; 117(2):261-95. DOI: 10.1161/CIRCULATIONAHA.107.188208. View

Merten G, Burgess W, Gray L, Holleman J, Roush T, Kowalchuk G . Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291(19):2328-34. DOI: 10.1001/jama.291.19.2328. View

Barrett B, Katzberg R, Thomsen H, Chen N, Sahani D, Soulez G . Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006; 41(11):815-21. DOI: 10.1097/01.rli.0000242807.01818.24. View

Ozcan E, Guneri S, Akdeniz B, Akyildiz I, Senaslan O, Baris N . Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective.... Am Heart J. 2007; 154(3):539-44. DOI: 10.1016/j.ahj.2007.05.012. View

McCullough P . Multimodality prevention of contrast-induced acute kidney injury. Am J Kidney Dis. 2008; 51(2):169-72. DOI: 10.1053/j.ajkd.2007.12.004. View

Bader B, Berger E, Heede M, Silberbaur I, Duda S, Risler T . What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol. 2004; 62(1):1-7. DOI: 10.5414/cnp62001. View

McCullough P, Adam A, Becker C, Davidson C, Lameire N, Stacul F . Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006; 98(6A):5K-13K. DOI: 10.1016/j.amjcard.2006.01.019. View

10.

Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Iacovis P, Greenwood D . Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004; 110(18):2837-42. DOI: 10.1161/01.CIR.0000146396.19081.73. View

11.

Hassoun H, Grigoryev D, Lie M, Liu M, Cheadle C, Tuder R . Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol. 2007; 293(1):F30-40. DOI: 10.1152/ajprenal.00023.2007. View

12.

Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D . The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007; 49(12):1283-8. DOI: 10.1016/j.jacc.2006.11.034. View

13.

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

14.

Verow P, Nossen J, Sheppick A, Kjaersgaard P . A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol. 1995; 68(813):973-8. DOI: 10.1259/0007-1285-68-813-973. View

15.

Hogan S, LAllier P, Chetcuti S, Grossman P, Nallamothu B, Duvernoy C . Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J. 2008; 156(3):414-21. DOI: 10.1016/j.ahj.2008.05.014. View

16.

Pugh N, Sissons G, Ruttley M, Berg K, Nossen J, Eide H . Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol. 1993; 47(2):96-9. DOI: 10.1016/s0009-9260(05)81180-8. View

17.

Manke C, Marcus C, Page A, Puey J, Batakis O, Fog A . Pain in femoral arteriography. A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers. Acta Radiol. 2003; 44(6):590-6. DOI: 10.1080/02841850312331287709. View

18.

Molitoris B, Levin A, Warnock D, Joannidis M, Mehta R, Kellum J . Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol. 2007; 3(8):439-42. DOI: 10.1038/ncpneph0551. View

19.

Band R, Gaieski D, Mills A, Sease K, Shofer F, Robey J . Discordance between serum creatinine and creatinine clearance for identification of ED patients with abdominal pain at risk for contrast-induced nephropathy. Am J Emerg Med. 2007; 25(3):268-72. DOI: 10.1016/j.ajem.2006.07.011. View

20.

Freeman R, ODonnell M, Share D, Meengs W, Kline-Rogers E, Clark V . Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002; 90(10):1068-73. DOI: 10.1016/s0002-9149(02)02771-6. View